Objective: To evaluate the capacity and effectiveness of trained community pharmacists in delivering the Diabetes Medication Assistance Service (DMAS) via (1) number and types of self-management support interventions (SMSIs); (2) number of goals set and attained by patients and (3) patient outcomes (glycaemic control, medication adherence and satisfaction).
Introduction
Worldwide, type 2 diabetes mellitus (T2DM) has been described as a major epidemic which imposes a huge cost burden on families, communities and health care systems. In Australia, according to recent national estimates, 7.2% of the population have T2DM [1] , half of whom have not yet been diagnosed [2] . The prevalence is expected to escalate in line with the continuing rise of risk factors that contribute to the development of T2DM. There is now conclusive evidence that intensive glycaemic control can reduce the risk and delay the onset of complications, and therefore improve the overall quality of life for people with T2DM [3] [4] [5] [6] [7] .
However, the achievement of strict glycaemic control is highly dependent on the extent to which an individual is able to self-manage their condition. Successful self-management of T2DM requires individuals to engage in various cognitive and behavioural processes on a daily basis to maintain blood glucose levels within the normal range, including lifestyle modifications, adherence to medications, self-monitoring of blood glucose (SMBG) and regular visits to health care professionals (HCPs). For many people with T2DM, selfmanagement is challenging as they do not possess adequate knowledge, skills and motivation to initiate and maintain behavioural changes to help them control their illness [8] [9] [10] .
A critical strategy to address this is to educate HCPs to empower patients to be proactive in the self-management of their condition. The use of motivational interviewing and collaborative goal setting to facilitate self-management support interventions (SMSIs) delivered by HCPs, has been shown to improve health outcomes for a range of chronic diseases including T2DM [11] [12] [13] [14] [15] . Motivational interviewing is a patient centered counseling approach designed to enhance the patient's intrinsic motivation for behavior change [16] . It is based on exploring patient beliefs about perceived difficulties in changing their behavior. The collaborative goal setting technique involves the negotiation and setting of small, achievable and specific goals by patients with the assistance of their HCP to address their most pressing problems. Each goal is supported by a strategy designed to help the patient achieve those goals. The attainment of behaviour change is optimized through the patient's personal investment in this process.
The positive effects of goal setting in changing behaviour may be explained by the selfefficacy theory [17] which suggests that successful goal attainment enhances self-efficacy by motivating the patient to set and pursue future goals [18] and increases resilience when faced with barriers in goal pursuit [19] . The goal setting technique has been recognised by the American Diabetes Association to be a key component of diabetes self-management education programs [20] .
Community pharmacies provide easily accessible HCPs for ongoing self-management support of chronic conditions such as asthma [21] and T2DM [22] . However, the training of pharmacists in behaviour change strategies and evaluation of their application in patients with T2DM has not been previously reported. A recent trial, the Diabetes Pilot Program, funded by the Australian Government Department of Health and Ageing as part of the Fourth Community Pharmacy Agreement, involved the development of a training program to prepare pharmacists to deliver the Diabetes Medication Assistance Service (DMAS), a care cycle of assessment, counseling, education and review for people with T2DM, provided at regular intervals at the pharmacy over a 6 month period.
The aim of this study was to evaluate (1) the impact of pharmacist training on the process of service delivery via the number and types of self-management support interventions (SMSIs) delivered by the DMAS pharmacists; (2) the impact of DMAS on patient self-management behaviours via the number and types of goals set and subsequently attained by patients and; (3) the impact of the DMAS on patients' outcomes including mean blood glucose levels, medication adherence and patient satisfaction with the service.
Methods

Ethics approval
Approval for this study was granted from the Human Research Ethics Committees at
The University of Sydney, New South Wales (NSW), Curtin University, Western Australia (WA), Monash University, Victoria (VIC) and The University of Tasmania, Tasmania (TAS).
Recruitment of pharmacies
The recruitment of 90 community pharmacies took place during November and December 2007. The pharmacy eligibility criteria included having a:
• Credentialed DMAS pharmacist
• Process to allow an uninterrupted DMAS consultation
• Screened counseling area or separate counseling room
Training and credentialing of the pharmacists
Participating pharmacists were required to complete a 2 day competency-based, face to face, training workshop on delivery of the DMAS. 
Patient recruitment and baseline assessment
Each pharmacy was asked to recruit up to 10 patients and eligible patients were those with T2DM who had an HbA 1c > 7.0, confirmed by their GP. On their first DMAS visit, patients were given a MediSense Optium Xceed™ blood glucose meter, instructed on its use, and then asked to take measurements at least once daily (preferably at different times). During this visit, the pharmacist recorded each patient's demographic details, diabetes history and current management, height, weight, smoking status, level of physical activity and medication adherence.
Pharmacist delivery of the DMAS Intervention
During the next 4 DMAS visits, the pharmacists used the Precision Link Direct 
Evaluation of processes and outcomes
The impact of DMAS was evaluated on a wide range of process and outcome measures ( Table 1 (strongly disagree) through to 5 (strongly agree). It comprises 3 subscales "service", "knowledge" and "self-management" [24] .
Patient qualitative interviews
To further investigate patient experiences with DMAS, interviews were conducted by telephone with a random sample, stratified by state, of 100 patients who had attended all 5 DMAS visits. The semi structured interviews, conducted by researchers, explored six core issues including overall experience, patient understanding of DMAS, patient expectations; pharmacists' delivery of the service; perceived need for an ongoing DMAS and willingness to pay.
Data analyses
The data were analysed using SPSS The patient interviews were tape recorded with permission, transcribed verbatim and thematically analysed.
Results
Training evaluation
Overall the training workshop was well rated by participants (Table 2) 
Recruitment and completion of DMAS patients
Patient demographics and diabetes history at baseline
The mean age for the entire cohort was 63 years with similar proportions of males and females (Table 3) . On average, patients had had diabetes for 10 years with the most commonly self-reported diabetes co-morbidities being high blood pressure and high cholesterol (Table 3) . At baseline, the majority of patients reported being treated with oral hypoglycaemic medications only (Table 4) .
Self-management support interventions (SMSI) delivered by the pharmacists
A total of 18,144 SMSIs were delivered by the pharmacists to patients during the DMAS consultations. The mean number of SMSIs per patient was 35 (SD ±31). DMAS patients received SMSIs relating to medication adherence (83%), medication use problems (51%), SMBG (80%) and lifestyle (77%) (Figure 1 ). SMSIs relating to medication adherence included education about medications, ability to access medications and insulin administration and were received by 83%, 55% and 47% of patients, respectively. SMSIs relating to medication use problems included drug or dose discrepancies, potential therapeutic problems, and "other" problems and were received by 46%, 42% and 44% of patients, respectively. SMSIs relating to SMBG included technique, hypoglycaemia and hyperglycaemia and were received by 80%, 65% and 72% of patients, respectively. Lifestyle
SMSIs included physical activity and nutrition advice being received by more than 70% of patients; smoking and alcohol SMSIs by 37% of patients; and foot care SMSIs by 65% of patients.
Total number of documented goals
The records for completed patients (n=387) were further evaluated to establish the number and types of goals set and attained. Of these, 347 (90%) had at least one documented goal in the patient file. The most common type of goal was physical activity (26%). This was followed by diet (23%), SMBG (15%) and the "other" category (8%) which comprised foot care, insulin dosage adjustment, blood pressure control and complications monitoring. One-third of the goals were attained while a greater proportion of goals were partially attained (53%). In contrast, only 14% of goals were not attained to any degree.
Baseline and final measures of the DMAS intervention
There was a significant reduction in the mean blood glucose levels (BGL) of patients In the BMQ adherence screens, patients showed a significant reduction in mean regimen, belief and total screen scores indicating a reduction in the risk of non-adherence to medication (Table 5 ). In terms of individual items making up the BMQ screens, there were reductions in the proportion of patients who reported stopping or interrupting therapy due to a late refill (from 9.7% to 7.5%); taking less than the prescribed amount (from 13.3% to 10.0%); taking more than the prescribed amount (from 3% to 1.4%);
or missing doses (from 22.4% to 18.7%). The proportion of patients who smoked decreased and, in addition, there was an increase in the proportion of patients who exercised three or more times per week, but these improvements were not statistically significant. There was no significant change in the proportion of patients exercising more than five times per week nor was there any change in BMI.
Patient satisfaction
A total of 323 patients completed the DDSM-Q at the end of the DMAS and the results showed that patients were highly satisfied with the "service" perspective of DMAS, which was centered on the delivery of the service by the pharmacist. The results of the sub-scales relating to patient satisfaction on "knowledge" and "self-management" of their diabetes are shown in Tables 6 and 7 
Patient Interviews
A number of distinct themes were identified. The majority of patients reported improvements in monitoring of their diabetes, medication adherence, lifestyle management and understanding of diabetes and its complications. Patients who were newly diagnosed with diabetes reported that they gained a lot of knowledge from the DMAS. In contrast, patients who had had diabetes for a number of years reported that while the DMAS did not necessarily increase their knowledge on diabetes, it increased their motivation to improve the management of their diabetes, especially lifestyle and medication issues supported by SMBG. 
Impact on knowledge of SMBG
Impact on knowledge of medications
In general patients reported improvements in understanding of diabetes medications and those on insulin therapy were better able to manage insulin dosing using the SMGB results.
"I learned that I was taking my medications incorrectly…should have been taking them before meals and I had been taking them after meals." (Patient 16, NSW) "Working out the balance between insulin and food intake ……and alter the units as needed. I tend to get hypos between midnight and 1am so need to control insulin amount in evenings." (Patient 2, WA)
Impact on knowledge of lifestyle
Patients reported that the pharmacist educated them about appropriate diet, exercise, alcohol and smoking and advised how improvements in lifestyle management played an important role in improving glycaemic control. In many cases, pharmacists referred patients to a dietician and the patient brought the dietician's report to subsequent DMAS visits for discussion with the pharmacist.
"It was fantastic because I had no control over my diabetes. I lost weight (14 kilos)." (Patient 17, NSW) "I have cut down on the number of cigarettes I smoke every day and only drink once a week now. More exercise and less cigarettes." (Patient 12, NSW) "I learnt a hell of a lot…..I have a better understanding of the effects of alcohol and exercise on my blood sugars." (Patient 18, NSW)
Discussion
The DMAS training workshops were well received by the pharmacists who expressed confidence in engaging their patients in diabetes self-management support and education.
Importantly, pharmacists reported that the training workshops had enabled them to apply their diabetes knowledge and skills during the DMAS trial. HCPs in the process of chronic care [25] .
The importance of review and monitoring of goals to support behavior change by patients was also underscored by the need to reset goals that had only been partially met at follow up visits which suggests that behavior change takes time. Goal setting is a process whereby the patient is often required to learn and master an entirely new cognitive skill (ie.
problem identification, setting attainable and realistic goals), while at the same time to develop mastery over changing entrenched habits. In particular, lifestyle factors such as losing weight or giving up smoking are not achievable within a short time-frame. To maintain patients' motivation for behavior change and maximize the likelihood of successfully attaining these goals, external sources of regular support and positive reinforcement from health professionals is critical [26] [27] [28] .
The patient processes evaluated during the DMAS showed that most patients had a least one documented goal and the most common of these related to lifestyle or SMBG.
There were very few goals set in relation to medications which may indicate a lack of patient "readiness" to set a specific goal that is relevant to them about their medications. The greater willingness of patients to set goals around lifestyle indicates that when patients are given choice in self-management of their chronic condition they are likely to focus on those aspects of self-management which are of most personal importance or relevance to them [21, 29] .
The essence of successful goal attainment is personal investment and the degree of perceived controllability an individual has over an event [28, 30, 31] . In the context of the current study, lifestyle changes may be viewed as more personally controllable than changes to medication regimens.
At the end of the DMAS, achievement of goals was reflected in the improved patient health outcomes. This indicates that the pharmacists could provide effective SMSIs to foster lifestyle changes to achieve glycaemic control and reduce the risk of complications [32] .
Furthermore, the level of goals which were attained suggests that the necessary skills, knowledge and motivation to drive behavior change strategies were acquired by patients during the DMAS.
Approximately one third of this patient cohort at baseline had not received any prior diabetes education. The reasons for this were not recorded but the willingness of these patients to participate in a community pharmacy diabetes education program may suggest a lack of other education programs for T2DM in the local area, or an increased convenience/accessibility of attending an education program at their local pharmacy. This was highlighted by the high level of patient satisfaction with the pharmacists' delivery of the DMAS as well as the environment and convenience of the pharmacy. There was strong support for continued availability of the DMAS in their local community pharmacy.
After the trial, a majority of DMAS patients reported having increased knowledge and motivation with respect to diabetes self-management. This was reflected in significant improvements in medication adherence scores and a significant reduction in mean blood glucose levels during the DMAS. The clinical effectiveness of the DMAS has been reported previously and included significant reductions in HbA 1c , blood pressure, total cholesterol and triglycerides [22] . Patients reported that they liked the pie charts and graphs printed by the pharmacist during the visits. The patient often brought a copy to a subsequent visit to the GP or specialist. The effectiveness of community based SMSIs delivered by trained HCPs immediately prior to a visit to the GP has been shown to empower patients to take a more pro-active approach in their interactions with their GP [33] . Patients who were newly diagnosed found the DMAS extremely useful as they had no previous understanding of diabetes or its complications. These individuals reported very significant improvements in lifestyle which is typically recommended for those newly diagnosed with T2DM [32] .
Furthermore, patients who were on insulin improved their ability to monitor and make adjustments to their insulin dose in response to blood glucose readings and changes in physical activity and food intake.
There were some limitations to this study. Firstly it did not include a control group, so we cannot be certain that the changes in outcomes were due to the pharmacist intervention alone. However the DMAS was previously tested in an RCT and shown to be clinically effective [22] . Much of the data, including adherence, goal setting and pharmacist interventions, were self-reported and therefore, may be subject to bias. To address this limitation, further improvements to the patient file documentation would be required in the future to optimize the recording of goal setting and pharmacist SMSIs.
Conclusion
Community 
Practice Implications
This study supports the feasibility and effectiveness of community pharmacists in supporting self-management behaviors of patients with T2DM. Based on evidence from large clinical trials [22] , the extent of improvement in diabetes control achieved by the DMAS will translate into future cost savings to the health care system in delaying and reducing diabetes related complications. 
Relevance of the workshop
Amount of information 
